AMO1Homo sapiens (Human)Cancer cell line

Also known as: AMO-1, AMo1

🤖 AI SummaryBased on 15 publications

Quick Overview

Human multiple myeloma cell line with B-cell lineage, used in cancer research.

Detailed Summary

The AMO1 cell line is a human multiple myeloma cell line derived from a B-cell lineage. It is widely used in cancer research to study the molecular mechanisms of multiple myeloma. This cell line has been characterized in various studies for its genetic and transcriptomic features, including chromosomal translocations and gene expression profiles. AMO1 is particularly noted for its utility in understanding the pathogenesis of multiple myeloma and in evaluating drug responses. It is part of a panel of cell lines used to model the disease's heterogeneity and to test therapeutic strategies.

Research Applications

Cancer researchDrug screeningGenomic studiesTranscriptomic analysis

Key Characteristics

B-cell lineageMultiple myelomaChromosomal translocationsGene expression profiling
Generated on 6/17/2025

Basic Information

Database IDCVCL_1806
SpeciesHomo sapiens (Human)
Tissue SourceAscites[UBERON:UBERON_0007795]

Donor Information

Age64
Age CategoryAdult
SexFemale

Disease Information

DiseaseMultiple myeloma
LineageLymphoid
SubtypePlasma Cell Myeloma
OncoTree CodePCM

DepMap Information

Source TypeDSMZ
Source IDACH-000838_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTET2p.Gln1699Ter (c.5095C>T)Heterozygous-Unknown, Unknown
MutationSimpleSTAT3p.Cys712Tyr (c.2135G>A)Heterozygous-Unknown, Unknown
MutationSimpleKRASp.Ala146Thr (c.436G>A)UnspecifiedIn 50% of the readsPubMed=27004849
MutationSimpleBCORp.Gln312del (c.932_934AGC[1]) (c.935_937delAGC)Heterozygous-Unknown
Gene fusionIGKJ2IGKV3-20-IGKJ2--CelloPub=CLPUB00604
Gene fusionIGKJ1IGKV1-8-IGKJ1--CelloPub=CLPUB00604

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
12
D12S391
17,19
D13S317
8
D16S539
9,13
D18S51
15,18
D19S433
15.2
D21S11
30,33.2
D2S1338
19
D3S1358
15,18
D5S818
12
D6S1043
11,19
D7S820
9,11
D8S1179
13,15
FGA
19,24
Penta D
9,15
Penta E
11
TH01
7,9
TPOX
8
vWA
17,18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Evaluating the efficacy of multiple myeloma cell lines as models for patient tumors via transcriptomic correlation analysis.

Sirota M., Wiita A.P.

Leukemia 34:2754-2765(2020).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Whole-exon sequencing of human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathways.

Pellat-Deceunynck C.

J. Hematol. Oncol. 11:137.1-137.13(2018).

Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines.

Yang H.H., Koeffler H.P.

BMC Cancer 18:940.1-940.13(2018).

Characterization of human cancer cell lines by reverse-phase protein arrays.

Liang H.

Cancer Cell 31:225-239(2017).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

A simple flow cytometry-based barcode for routine authentication of multiple myeloma and mantle cell lymphoma cell lines.

Moreau-Aubry A., Amiot M., Pellat-Deceunynck C.

Cytometry A 87:285-288(2015).

A comprehensive transcriptional portrait of human cancer cell lines.

Settleman J., Seshagiri S., Zhang Z.-M.

Nat. Biotechnol. 33:306-312(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines.

Pellat-Deceunynck C.

Haematologica 96:574-582(2011).

Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles.

Todoerti K., Ronchetti D., Lambertenghi-Deliliers G., Neri A.

Genes Chromosomes Cancer 48:521-531(2009).

Molecular characterization of human multiple myeloma cell lines by integrative genomics: insights into the biology of the disease.

Lambertenghi-Deliliers G., Bertoni F., Neri A.

Genes Chromosomes Cancer 46:226-238(2007).

An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma.

Fabris S., Lambertenghi-Deliliers G., Neri A.

BMC Med. Genomics 1:37.1-37.9(2008).

Overexpression of PDZK1 within the 1q12-q22 amplicon is likely to be associated with drug-resistance phenotype in multiple myeloma.

Taniwaki M., Inazawa J.

Am. J. Pathol. 165:71-81(2004).

Inactivation of the E3/LAPTm5 gene by chromosomal rearrangement and DNA methylation in human multiple myeloma.

Miura I., Dave B.J., Sanger W.G., Lim B., Taniwaki M., Ueda R.

Leukemia 17:1650-1657(2003).

Ectopic expression of MAFB gene in human myeloma cells carrying (14;20)(q32;q11) chromosomal translocations.

Sonta S.-i., Nitta M., Taniwaki M., Ueda R.

Jpn. J. Cancer Res. 92:638-644(2001).

Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia.

Drexler H.G., Matsuo Y.

Leuk. Res. 24:681-703(2000).

Expression of the TCL1 gene at 14q32 in B-cell malignancies but not in adult T-cell leukemia.

Aizawa Y., Ueda R., Seto M.

Jpn. J. Cancer Res. 89:712-718(1998).

Establishment of a CD4-positive plasmacytoma cell line (AMO1).";

Fukuhara S., Ohno H., Isobe Y., Konda S.

Leukemia 7:274-280(1993).

The leukemia-lymphoma cell line factsbook.";

Drexler H.G.

(In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).

Multiple myeloma cell lines.";

Jernberg-Wiklund H., Nilsson K.

(In book chapter) Human cell culture. Vol. 3. Cancer cell lines part 3; Masters J.R.W., Palsson B.O. (eds.); pp.81-155; Kluwer Academic Publishers; New York; USA (2000).